Advertisement

The Role of N-Linked Glycosylation in the Secretion of Hepatitis B Virus

  • Anand Mehta
  • Timothy M. Block
  • Raymond A. Dwek
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 435)

Abstract

Hepatitis B virus (HBV) is the human member of the hepadnaviradae family of viruses which chronically infects over 300 million people worldwide. Infection by HBV can lead to both acute and chronic liver disease. For those unfortunate to become chronic carriers of HBV, there are lifelong complication associated with the virus. Indeed up to 40% of chronic carriers may eventually develop hepatocellular carcinoma (1). As there is such a large pool of chronic carriers, it can be assumed that a vast number of the worlds population die from complications that arise from infection with HBV.

Keywords

Glycan Structure Chronic Carrier Glycan Site Glycan Processing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Beasley, R. P. (1988). The Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer. 61: 1942–1956.PubMedCrossRefGoogle Scholar
  2. 2).
    Heermann, K.H., Gerlich, W.H. (1992) In: Mol. Biol of HBV, A Maclachlan, ed, CRC Press, Boca Raton Fl.Google Scholar
  3. 3).
    Heerman, H-H, Goldman, I., Schwartz, W., Seyffarth, T., Baumgarten, H. Gerlich, W. H. (1984) Large surface proteins of hepatitis b virus containing preS sequence. J. Virol 52: 396–402.Google Scholar
  4. 4).
    Bruss, V., D. Ganem. (1991). The role of envelope proteins in hepatitis b virus assembly. Proc. Natl. Acad. Sci. USA. 88: 1059–1063.PubMedCrossRefGoogle Scholar
  5. 5).
    Ueda, K., T. Tsurimoto and K. Matsbara (1991) Three envelope proteins of hepatitis B virus: large S, middle S and major S proteins needed for the formatioin of Dane particles. J. Virol. 65: 3521–3529.PubMedGoogle Scholar
  6. 6).
    Ganem, D. (1991) Current topics in Microbiol, and Immunol. (W. Mason and C. Seeger, Eds.) 168, 61–84.Google Scholar
  7. 7).
    Patzer, E., Nakamura, G., Yaffe, A. (1984) Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells. J. Virol. 51: 346–353PubMedGoogle Scholar
  8. 8).
    Sheu, S. Y. and Lo, S. J. (1994) Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway. J. General Virol. 75, 3031–3039.CrossRefGoogle Scholar
  9. 9).
    Lu, X., Mehta, A., Butters,T., Dwek, R.A., Block, T.M. (1995) Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virol. 213, 660–665.CrossRefGoogle Scholar
  10. 10).
    Block, T., Platt, F., Xuanyong, L., Gerlich, W., Foster, G., Blumberg, B., Dwek, R. (1994) Secretion of human hepatitis B virus is inhibited by the imino sugar, N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. (USA) 91: 2235–2239.CrossRefGoogle Scholar
  11. 11).
    Lu, X., Block, T., Gerlich, W.H. (1996) Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J. Virol. 70, 2277–2285.PubMedGoogle Scholar
  12. 12).
    Guile, G.R., Wong, S.Y.C., Dwek, R.A. (1994) Analytical and preparative separation of anionic oligosaccharides by weak anion-exchange high performance liquid chromatography on an inert polymer column. Anal. Biochem. 222, 231–235.PubMedCrossRefGoogle Scholar
  13. 13).
    Guile, G.R., Rudd, P., Wing, D., Prime, S.B., Dwek, R.A. (1996) A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 240, 210–226.PubMedCrossRefGoogle Scholar
  14. 14).
    Lu, X., Mehta, A., Dadmarz, M., Dwek, R.A., Blumberg, B.S., Block, T.M. (1996) Aberrant trafficking and behavior of hepatitis B virus glycoproteins in cells in which glycosylation processing is inhibited. Submitted to Proc. Natl. Acad. Sci. (USA).Google Scholar
  15. 15).
    Datema, S. Olofsson, P. Romero. (1987) Inhibitors of protein glycosylation and glycoprotein processing in viral systems. Pharmacol. Thera. 33: 221–286CrossRefGoogle Scholar
  16. 16).
    Lodish, H., A. Kong (1984). Glucose removal from N linked oligosacchairdes is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulim to the Golgi compartment. J. Cell. Biol. 98: 1720–1729.PubMedCrossRefGoogle Scholar
  17. 17).
    Ou, W.J., Cameron, P.H., Thomas, D.Y., Bergeron, J.M. (1993) Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364, 771–776.PubMedCrossRefGoogle Scholar
  18. 18).
    Helenius, A. (1994) How N linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol. Biol. Cell. 5: 253–265.PubMedGoogle Scholar
  19. 19).
    Sells, M.A., M. L. Chen, G. Acs, (1987). Production of hepatitis b virus particles in Hep G2 cells transfected with cloned hepatitis b virus DNA. Proc. Natl. Acad. Sci. USA. 84: 1005–1009.PubMedCrossRefGoogle Scholar
  20. 20).
    Moore, S. E., Spiro, R.G. (1990) Demonstration that Golgi endo-α-D-mannosidase provides a glucosidase independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins. J. Biol. Chem. 265, 13104–13112.PubMedGoogle Scholar
  21. 21).
    Karlsson, G.B., Butters, T. D., Dwek, R.A., Platt, F.M., (1993) Effects of the imino sugar N butyldeoxynojirimycin on the N glycosylation of recombinant gp120 J. Biol. Chem. 268: 570–576.PubMedGoogle Scholar
  22. 22).
    Poulter, L., Burlingame, A.L. (1990) Methods in Enzymology 193, 661–689.PubMedCrossRefGoogle Scholar
  23. 23).
    Dwek, R.A. (1996) Glycobiology: Towards understanding the function of sugars. Chemical Reviews, 96, 683–720.PubMedCrossRefGoogle Scholar
  24. 24).
    Fisher, P.B., Karlsson, G.B., Dwek, R.A., Platt, F.M. (1996) N-Butyldeoxynojirimycin-mediated inhibitionof human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure. J. Virol 70, 7153–7160.Google Scholar
  25. 25).
    Fisher, P.B., Karlsson, G.B., Butters, T.D., Dwek, R.A., Platt, F.M. (1996) N-Butyldeoxynojirimycin-mediated inhibitionof human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gpl20. J. Virol. 70, 7143–7152.Google Scholar
  26. 26).
    Petrescu, S.M., Petrescu, A.J., Dwek, R.A., Platt, F.M. (1996) Inhibition of N-glycan processing in B16 melanoma cells results in inactivation of tyrosinase but does not prevent its transport to the melanosome. Accepted J. Biochemistry.Google Scholar
  27. 27).
    Fernholz, D., Galle, P.R., Stemler, M., Brunetto, M., Bonino, F., Will, H. (1993) Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194, 137–148.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Anand Mehta
    • 1
  • Timothy M. Block
    • 2
  • Raymond A. Dwek
    • 1
  1. 1.The Glycobiology Institute, Department of BiochemistryOxford UniversityOxfordUK
  2. 2.Viral Hepatitis Group, Kimmel Cancer CenterJefferson Medical CollegePhiladelphiaUSA

Personalised recommendations